We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
+17.19%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
–
AUM
$2.26B
AUM Growth
+$384M
Cap. Flow
+$115M
Cap. Flow %
5.09%
Top 10 Hldgs %
22.4%
Holding
443
New
33
Increased
160
Reduced
64
Closed
38

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$39.7M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$14.6M
3
AGIO icon
Agios Pharmaceuticals
AGIO
+$10.1M
4
WLK icon
Westlake Corp
WLK
+$8.6M
5
BKNG icon
Booking.com
BKNG
+$6.85M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$26.3M
2
CELG
Celgene Corp
CELG
+$20.8M
3
TIF
Tiffany & Co.
TIF
+$8.44M
4
SOXX icon
iShares Semiconductor ETF
SOXX
+$7.14M
5
ROP icon
Roper Technologies
ROP
+$5.77M

Sector Composition

Rank Sector Weight
1 Healthcare 30.75%
2 Technology 20.83%
3 Consumer Discretionary 14.53%
4 Financials 9.34%
5 Miscellaneous 6.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FSV icon
101
FirstService
FSV
$5.74B
$5.6M 0.25%
60,000
+8,000
+15% +$753K
OPLN
102
Openlane
OPLN
$4.26B
$5.53M 0.24%
255,000
+11,000
+5% +$251K
JNCE
103
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$5.47M 0.24%
672,687
+40,000
+6% +$216K
XNCR icon
104
Xencor
XNCR
$1.77B
$5.3M 0.23%
154,200
– –
PNC icon
105
PNC Financial Services
PNC
$96.1B
$5.24M 0.23%
32,665
-5,662
-15% -$850K
TPIC
106
DELISTED
TPI Composites
TPIC
$5.15M 0.23%
278,484
+8,884
+3% +$163K
CRM icon
107
Salesforce
CRM
$210B
$5.13M 0.23%
31,090
+300
+1% +$47K
GBT
108
DELISTED
Global Blood Therapeutics, Inc.
GBT
$5.05M 0.22%
63,800
– –
GH icon
109
Guardant Health
GH
$23.6B
$5M 0.22%
+63,500
New +$4.58M
NOVA
110
DELISTED
Sunnova Energy
NOVA
$5M 0.22%
430,000
+320,000
+291% +$3.33M
CMCSA icon
111
Comcast
CMCSA
$86.7B
$4.98M 0.22%
110,401
+10,990
+11% +$489K
ZGNX
112
DELISTED
Zogenix, Inc.
ZGNX
$4.91M 0.22%
94,900
– –
TERP
113
DELISTED
TerraForm Power, Inc
TERP
$4.82M 0.21%
317,490
-20,000
-6% -$322K
RETA
114
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$4.78M 0.21%
22,600
– –
ICE icon
115
Intercontinental Exchange
ICE
$88.1B
$4.74M 0.21%
51,103
+4,832
+10% +$448K
MFC icon
116
Manulife Financial
MFC
$72.7B
$4.69M 0.21%
232,500
+10,100
+5% +$193K
PFE icon
117
Pfizer
PFE
$157B
$4.63M 0.2%
124,077
+8,959
+8% +$319K
ONC
118
BeOne Medicines Ltd
ONC
$39.2B
$4.61M 0.2%
27,600
– –
KYNB
119
Kyntra Bio
KYNB
$31.5M
$4.43M 0.2%
3,944
+996
+34% +$1.02M
GIL icon
120
Gildan
GIL
$8.5B
$4.39M 0.19%
148,600
-25,500
-15% -$746K
AMD icon
121
Advanced Micro Devices
AMD
$823B
$4.39M 0.19%
95,000
+15,000
+19% +$552K
VYGR icon
122
Voyager Therapeutics
VYGR
$190M
$4.33M 0.19%
320,900
+15,000
+5% +$218K
TD icon
123
Toronto Dominion Bank
TD
$199B
$4.31M 0.19%
76,660
-1,750
-2% -$99.2K
LLY icon
124
Eli Lilly
LLY
$1.01T
$4.29M 0.19%
32,600
+2,100
+7% +$243K
BEP icon
125
Brookfield Renewable
BEP
$8.65B
$4.16M 0.18%
166,633
-15,012
-8% -$354K
3 4
5
6 7

Similar funds

FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
WI
WealthNavi Inc Shinagawa-Ku, Tokyo, Japan $12.8B AUM 19.73% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
VLKIM
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $13.1B AUM 19.56% 1-Year Est. Return
BAMF
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $12.6B AUM 41.69% 1-Year Est. Return

Erste Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, Erste Asset Management held 443 positions worth $2.26B, up 20% from $1.88B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Erste Asset Management deployed $115M of net new capital in Q4 2019, opening 33 new positions and adding to 160 existing holdings. Its largest new stake was Westlake Corp: 128,000 shares worth $8.83M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 29% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $26.3M trimmed.

  • Erste Asset Management's largest Q4 2019 buy was Westlake Corp: 128,000 shares worth $8.83M.
  • Erste Asset Management added most to Biogen in Q4 2019, an estimated $39.7M increase.
  • Erste Asset Management's biggest Q4 2019 reduction was Vertex Pharmaceuticals, cutting an estimated $26.3M.
  • Erste Asset Management fully exited Celgene Corp in Q4 2019, selling an estimated $20.8M.
  • Erste Asset Management's ten largest holdings make up 22% of its $2.26B portfolio in Q4 2019.
  • Erste Asset Management opened 33 new positions and closed 38 in Q4 2019.
  • Erste Asset Management's portfolio value rose 20% quarter-over-quarter to $2.26B.

Based on Erste Asset Management's 13F filing for Q4 2019, filed 22 Nov 2024.